trial Salipro Biotech is attending the 3rd Advanced Therapy Showcase in Tokyo, Japan, organized by LINK-J

protein and has evolved to achieve resolutions comparable to X-ray crystallography (García-Nafría, J. H., & Lee, J.

., J. García-Nafría, and C.G.

Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics

Sosei Heptares’ Partner, Pfizer, Progresses Its GLP-1 Receptor Agonist PF-06954522 into a Phase 1 Trial Andrew

Deadline September 27, 2023 GPCR Events, Meetings, and Webinars October 2 - 3, 2023 | Celebrating Robert J.

Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease

on Conformational dynamics underlying atypical chemokine receptor 3 activation   Michael Trogdon , J

et al. for their study on Frizzleds act as dynamic pharmacological entities Marina Casiraghi, Robert J

Design through GPCR Mutagenesis: Insights from β2AR China M Payne ,   Cam Sinh Lu ,   Karen Gregory ,  Lauren May ,  Andrea Vernall , et al. for their fantastic paper on Development of Putative Bivalent Dicovalent

molecules which initiate a neuronal response that drives odorant discrimination and perception (Young J.

PMID: 38378098 Curated by Sumit J. Bandekar with help from Nathan Zaidman and Abhishek K. Singh

Chakit Arora, J Silvio Gutkind, and Francesco Raimondi for their work on The landscape of cancer-rewired

N-termini that mediate ligand binding and signaling (Bannert N et al. 2001; Casarosa P et al. 2005; Gao J

In the context of MCMV latency, spleen explants from M33ΔC38-infected mice were markedly attenuated for

Kawthar Belkacemi , Philippe Rondard , Jean-Philippe Pin , and Laurent Prézeau ,   for their research

Stuart Maudsley, Nicole Perry-Hauser, Lauren Slosky, Cesare Orlandi, and Simone Prömel.